Associate Professor of Hematology
University of Milan
Niccolo Bolli is an associate professor of hematology at the University of Milan, Italy, and a consultant in hematology at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico where he also leads the research and diagnostics laboratory.
He received his MD and trained in Haematology at the University of Perugia, where he also developed research interests in the field of malignant haematopoiesis. Niccolo then moved to Boston, where he spent his PhD years in the laboratory of A. Thomas Look at the Dana-Farber Cancer Institute/Harvard Medical School, working on animal model systems to study alterations in haematopoiesis promoted by mutations in genes involved in leukemia and other genes involved in RNA processing and splicing. In 2011, Niccolo joined the University of Cambridge, UK, where he worked as a clinical lecturer in hematology and mostly performed research in the Cancer Genome Project led by Peter Campbell at the the Wellcome Trust Sanger Institute. There, he studied the influence of splice factor genes mutations in haematopoiesis, and started a new field of research on multiple myeloma genomics. His work on myeloma genomics has been mostly focused on characterizing the genomic spectrum of alterations in this malignancy, and on the study of heterogeneity and clonal evolution from diagnosis to chemoresistant samples. In Milan, he is working as a clinician and is continuing research in the field of genomics of haematological malignancies. Among his lines of research are: the evolutionary aspects of multiple myeloma from pre-clinical and asymptomatic conditions to overt disease; the use of genomics to develop prognostic markers of progression; the search for predictive markers of treatment response.
He is currently recipient of several national and international grants on those topics.
Niccolo authored 111 documents, has over 14,000 citations and an H-index of 40 (Scopus, April 2023).
Meet the Professor: Optimizing in vitro cellular models of MM
Friday, September 29, 2023
7:00 AM – 8:00 AM EEST